Literature DB >> 23313159

Molecular characterization of a mosaic NIPBL deletion in a Cornelia de Lange patient with severe phenotype.

Cristina Gervasini1, Ilaria Parenti, Chiara Picinelli, Jacopo Azzollini, Maura Masciadri, Anna Cereda, Angelo Selicorni, Silvia Russo, Palma Finelli, Lidia Larizza.   

Abstract

Cornelia de Lange syndrome (CdLS, OMIM #122470, #300590, #610759, #614701, #300882) is a rare neurodevelopmental syndrome characterized by growth retardation, intellectual disability, dysmorphic facial features, multisystem malformations, and limb reduction defects. Wide variability of phenotypes is common among CdLS patients. Mutations in genes encoding either regulators (NIPBL, HDAC8) or subunits (SMC1A, SMC3, RAD21) of the cohesin complex, are altogether found in approximately 65% of CdLS patients. We describe a CdLS patient with classic severe phenotype who was found negative to mutations in the NIPBL and SMC1A genes by DHPLC and direct sequencing. MLPA analysis performed to disclose potential intragenic NIPBL deletions/duplications, suggested a partial deletion which was confirmed by FISH with a BAC clone encompassing the NIPBL region that highlighted asymmetric signals in a fraction of cells (72%). The occurrence of a genomic deletion in mosaic condition was validated by array-CGH analysis. Long-range PCR and sequencing of the junction fragment mapped the telomeric and the centromeric breakpoint within NIPBL IVS1 and IVS32, respectively. Both deletion breakpoints were embedded in a microsatellite region that might be the motif directly mediating this large deletion by an intrachromatid recombination mechanism. Consistent with the molecular analyses, the patient displayed a severe phenotype that was characterized by drastic CdLS clinical signs including premature death. This case provides a second example of mosaicism in CdLS. Despite mitigated by mosaicism, the large intragenic deletion identified in the present case was poorly tolerated due to the high mosaicism level. Based on these data, overlooked cases of mosaicism may lead to underestimated mutation rates of known genes and may also contribute to the clinical heterogeneity of CdLS.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313159     DOI: 10.1016/j.ejmg.2012.12.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

Review 1.  The genome in three dimensions: a new frontier in human brain research.

Authors:  Amanda C Mitchell; Rahul Bharadwaj; Catheryne Whittle; Winfried Krueger; Karoly Mirnics; Yasmin Hurd; Theodore Rasmussen; Schahram Akbarian
Journal:  Biol Psychiatry       Date:  2013-08-16       Impact factor: 13.382

Review 2.  The future of neuroepigenetics in the human brain.

Authors:  Amanda Mitchell; Panos Roussos; Cyril Peter; Nadejda Tsankova; Schahram Akbarian
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 3.  Understanding the genetic liability to schizophrenia through the neuroepigenome.

Authors:  John F Fullard; Tobias B Halene; Claudia Giambartolomei; Vahram Haroutunian; Schahram Akbarian; Panos Roussos
Journal:  Schizophr Res       Date:  2016-01-27       Impact factor: 4.939

4.  Copy number analysis of NIPBL in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion.

Authors:  Yu-Wei Cheng; Christopher A Tan; Agata Minor; Kelly Arndt; Latrice Wysinger; Dorothy K Grange; Beth A Kozel; Nathaniel H Robin; Darrel Waggoner; Carrie Fitzpatrick; Soma Das; Daniela Del Gaudio
Journal:  Mol Genet Genomic Med       Date:  2013-11-14       Impact factor: 2.183

5.  Regulation of the cohesin-loading factor NIPBL: Role of the lncRNA NIPBL-AS1 and identification of a distal enhancer element.

Authors:  Jessica Zuin; Valentina Casa; Jelena Pozojevic; Petros Kolovos; Mirjam C G N van den Hout; Wilfred F J van Ijcken; Ilaria Parenti; Diana Braunholz; Yorann Baron; Erwan Watrin; Frank J Kaiser; Kerstin S Wendt
Journal:  PLoS Genet       Date:  2017-12-20       Impact factor: 5.917

Review 6.  Impaired Regulation of Histone Methylation and Acetylation Underlies Specific Neurodevelopmental Disorders.

Authors:  Merrick S Fallah; Dora Szarics; Clara M Robson; James H Eubanks
Journal:  Front Genet       Date:  2021-01-08       Impact factor: 4.599

Review 7.  The role of somatic mosaicism in brain disease.

Authors:  Alexandre Jourdon; Liana Fasching; Soraya Scuderi; Alexej Abyzov; Flora M Vaccarino
Journal:  Curr Opin Genet Dev       Date:  2020-07-01       Impact factor: 5.578

8.  A novel mosaic variant on SMC1A reported in buccal mucosa cells, albeit not in blood, of a patient with Cornelia de Lange-like presentation.

Authors:  Aixa Gonzalez Garcia; Julia Malone; Hong Li
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-06-12

9.  Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in blood.

Authors:  Ana Latorre-Pellicer; Marta Gil-Salvador; Ilaria Parenti; Cristina Lucia-Campos; Laura Trujillano; Iñigo Marcos-Alcalde; María Arnedo; Ángela Ascaso; Ariadna Ayerza-Casas; Rebeca Antoñanzas-Pérez; Cristina Gervasini; Maria Piccione; Milena Mariani; Axel Weber; Deniz Kanber; Alma Kuechler; Martin Munteanu; Katharina Khuller; Gloria Bueno-Lozano; Beatriz Puisac; Paulino Gómez-Puertas; Angelo Selicorni; Frank J Kaiser; Feliciano J Ramos; Juan Pié
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.